Endometriosis is defined as the presence of viable endometrial glands and stroma outside of the uterus. Endometrial foci may give rise to malignant tumours, it is estimated at 0,7-1,0%. Women with endometriosis have a two-to threefold increase in absolute risk of developing epithelial ovarian cancer, especially clear cell and endometrioid subtypes, seromucinous tumours known as endometriosis-associated ovarian carcinoma (EAOC).
We present a case of 44 years old patient hospitalised in case of surgical treatment of ovarian cancer at the I Department of Gynecology and Obstetrics. During medical interview the patient reported short menstrual cycles, periodic abdominal pain and infertility, diagnosis of endometriosis has never been confirmed. The result of CA 125 was elevated (156.0 U/ml). Furthermore, during ultrasound, an ovarian mass sized 6 cm was detected and hypoechogenic infiltration with rich vascularisation was recognised in the middle of the cervix. Cytology of the cervix which was performed in Clinic-without abnormalities. During the operation a full oncological protocol for ovarian cancer was performed -in the intraoperative histopathological examination: malignant lesion. After the excision of the uterus the infiltration was confirmed, the iliac lymph nodes were collected on both sides. In diagnostic material ovarian cancer endometrioid subtypes was diagnosed, additionally endometrioma was described in which probably cancer progression had occurred. What's more synchronous endometrial cancer of an identical structure to ovarian tumour was diagnosed.
There is potential correlation between occurrence of endometriosis and risk of developing malignant tumours. CA 125 antigen can help as an alert marker and prognostic factor. We should seek to eliminate the risk factors for ovarian and endometrial cancer in patients with diagnosed endometriosis, they should be under permanent gynecological care.
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Rare adenomatoid tumour of the uterus
A 33-year-old, white previously healthy woman (gravida 0, para 0) was referred to our hospital with a gross abdominal tumour, which was diagnosed during routine screening ultrasound. Patient had the sensation of fullness of abdomen, leading to decreased appetite. There was no history of abnormal uterine bleedings. There was no family history of malignancies. The patient had no history of the previous medical or surgical illnesses. Physically, the tumour was firm and bump up to a height of two fingers below the navel. A blood test revealed low hemoglobin level (9,9 g/dl), ca-125 level was 98,9U/ml, ca 19,9 6,8U/ml. A transvaginal ultrasonography demonstrated irregular multilocular-solid lesion measuring 12x10x9cm localised in close connection with posterior uterine wall and the left ovary. Solid component was irregular, did not present any acoustic shadowing and measured 6,3x6,2x6,7cm. Objectives: The aim of this study was to determine sensitivity, specificity, positive and negative predictive values and 95% confidence intervals for ultrasound in characterisation of ovarian masses in patients presenting at the university hospital of Vienna, Austria. Methods: A retrospective study design was used to collect data from 2009 to 2015 from medical records of the general hospital in Vienna, Austria. Using a non-probability purposive sampling technique, a sample of 292 women aged between 15 and 89 years was recruited.
The inclusion criteria were a pre-surgical ultrasound examination and a histopathologically proven ovarian mass. Results: Specificity of ultrasound due to pattern recognition was 90,7% (95%-CI, 87,2-94,2%) and sensitivity was 64,5% (95%-CI, 48,0-81,3%) respectively. Positive predictive value was 45,5% (95%-CI, 30,3-59,7%) and negative predictive value was 95,5% (95%-CI, 92,9-98,1%). A total of 292 ovarian masses were detected, out of which 31 were histopathologically malignant and 261 were benign. Vascularisation of the adnexal mass as well as the presence of papillary projections and a solid appearance of the mass were identified as essential risk factors for a malignant event.
Conclusions: Results of our study further reinforce the conclusion that ultrasound should be used as an initial modality of choice in the workup of every woman with an ovarian mass. Due to the risk of misclassification of malignomas and borderline tumours as benign masses, there is a need to improve subjective pattern recognition using defined sonomorphological characteristics.
